| Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser. | |
| | |
MedLine Citation:
|
PMID: 17052541 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nodular basal cell carcinomas resistant to multiple forms of treatment in two patients with nevoid basal cell carcinoma syndrome (Gorlin's syndrome) were treated with systemic porfimer sodium-based photodynamic therapy. Interstitially placed optical diffuser fibers were used to deliver light. Good response to treatment was seen on clinical evaluation and on measurement by a 20-MHz high-resolution ultrasound. |
| | |
Authors:
|
Vishal Madan; Juliette A Loncaster; Donald Allan; John T Lear; Linda Sheridan; Catherine Leach; Ernest Allan |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2006-08-28 |
Journal Detail:
|
Title: Journal of the American Academy of Dermatology Volume: 55 ISSN: 1097-6787 ISO Abbreviation: J. Am. Acad. Dermatol. Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2006-10-20 Completed Date: 2007-03-19 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 7907132 Medline TA: J Am Acad Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: S86-9 Citation Subset: IM |
Affiliation:
|
Dermatology Centre, Hope Hospital, Salford, Manchester, M6 8HD, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Basal Cell Nevus Syndrome / drug therapy* Carcinoma, Basal Cell / drug therapy* Dihematoporphyrin Ether / therapeutic use Humans Laser Therapy Male Middle Aged Optics and Photonics Photochemotherapy* Photosensitizing Agents / therapeutic use Skin Neoplasms / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Photosensitizing Agents; 97067-70-4/Dihematoporphyrin Ether |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chemoradiation using low-dose cisplatin and 5-fluorouracil in locally advanced squamous cell carcino...
Next Document: Gifts to physicians from the pharmaceutical industry: an ethical analysis.